The IL-4 and IL-5 levels in serum were significantly suppressed by BSYQ 13g/kg and 26g/kg treatment, on the contrary, IFN-γ levels were markedly increased in BSYQ 26g/kg treatment group, as compared with that of AD control mice (p<0.05). Here, IL4 is linked to Alzheimer disease.